Log In
BCIQ
Print this Print this
 

AADvac1

  Manage Alerts
Collapse Summary General Information
Company Axon Neuroscience SE
DescriptionActive vaccine containing synthetic peptide derived from microtubule-associated protein tau (tau; MAPT; FTDP-17) coupled to keyhole limpet hemocyanin (KLH)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat mild Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today